Literature DB >> 3625480

Generalizations in linear pharmacokinetics using properties of certain classes of residence time distributions. II. Log-concave concentration-time curves following oral administration.

M Weiss.   

Abstract

The present approach enables a noncompartmental assessment of log-concave plasma concentration-time profiles following oral drug administration. Observed log-concavity corresponds to a nonparametric class of residence time distributions with the following properties: (1) The fractional rate of elimination kB(t) (failure rate of the distribution) increases monotonically until reaching the terminal exponential coefficient kB,Z. (2) The relative dispersion of body residence times CVB2 (ratio of variance to the squared mean, VBRT/MBRT2) acts as a shape parameter of the curve. The role of the input process in determining the shape of the concentration profile is discussed. In this connection evidence is provided for the importance of log-concave percent undissolved versus time plots, introducing the general concept of a time-varying fractional rate of dissolution. The governing factor for the appearance of log-concavity is the ratio of mean absorption time to mean disposition residence time (MAT/MDRT); this factor exceeds a particular threshold value which depends on the distributional properties of the drug. Generalizing previous approaches which are valid for first-order input processes, the "flip-flop" phenomenon and the problem of "vanishing of exponential terms" are explained using fewer assumptions. Upper bounds for the elimination time (more than 90% eliminated) and the cutoff error in AUC determination are presented. The concept of log-concavity reveals general features of the pharmacokinetic behavior of oral dosage forms exhibiting a dominating influence of the absorption/dissolution process.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3625480     DOI: 10.1007/BF01062939

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  9 in total

1.  Critical analysis of "flip-flop" phenomenon in two-compartment pharmacokinetic model.

Authors:  P R Byron; R E Notari
Journal:  J Pharm Sci       Date:  1976-08       Impact factor: 3.534

2.  A general model of metabolite kinetics following intravenous and oral administration of the parent drug.

Authors:  M Weiss
Journal:  Biopharm Drug Dispos       Date:  1988 Mar-Apr       Impact factor: 1.627

3.  Bioavailability of digoxin from tablets. III. Availability of digoxin in man from preparations with different dissolution rate.

Authors:  L Nyberg; K E Andersson; A Bertler
Journal:  Acta Pharm Suec       Date:  1974-11

4.  Generalizations in linear pharmacokinetics using properties of certain classes of residence time distributions. I. Log-convex drug disposition curves.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1986-12

5.  Use of gamma distributed residence times in pharmacokinetics.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Theorems on log-convex disposition curves in drug and tracer kinetics.

Authors:  M Weiss
Journal:  J Theor Biol       Date:  1985-10-07       Impact factor: 2.691

7.  In vitro--in vivo correlation of dissolution, a time scaling problem? Transformation of in vitro results to the in vivo situation, using theophylline as a practical example.

Authors:  D Brockmeier; H J Dengler; D Voegele
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Assessment of drug absorption after oral administration.

Authors:  K K Chan; M Gibaldi
Journal:  J Pharm Sci       Date:  1985-04       Impact factor: 3.534

9.  Prediction of blood levels following oral administration of weakly acidic drug particles such as sulfa drugs in rabbits from the in vitro dissolution behavior.

Authors:  N Watari; N Kaneniwa
Journal:  J Pharmacobiodyn       Date:  1984-06
  9 in total
  4 in total

1.  The relevance of residence time theory to pharmacokinetics.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

Authors:  P Veng-Pedersen
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

3.  A novel extravascular input function for the assessment of drug absorption in bioavailability studies.

Authors:  M Weiss
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

4.  Empirical models for fitting of oral concentration time curves with and without an intravenous reference.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-01       Impact factor: 2.745

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.